K233904

Substantially Equivalent

ACIST RXi System (016616); ACIST Navvus II Catheter (016675_

Applicant: Acist Medical Systems, Inc.
Product code: DXO
Advisory panel: Cardiovascular
Date received: 2023-12-11
Decision date: 2024-07-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Eden Prairie, MN, US

Adverse events under product code DXO

product code DXO

Death: 10
Injury: 156
Malfunction: 884
Total: 1,050

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.